Admixture mapping of end stage kidney disease genetic susceptibility using estimated mutual information ancestry informative markers

<p>Abstract</p> <p>Background</p> <p>The question of a genetic contribution to the higher prevalence and incidence of end stage kidney disease (ESKD) among African Americans (AA) remained unresolved, until recent findings using admixture mapping pointed to the associati...

Full description

Bibliographic Details
Main Authors: Geiger Dan, Templeton Alan, Yudkovsky Guennady, Wasser Walter G, Bercovici Sivan, Shlush Liran I, Skorecki Karl
Format: Article
Language:English
Published: BMC 2010-10-01
Series:BMC Medical Genomics
Online Access:http://www.biomedcentral.com/1755-8794/3/47
id doaj-21e94783fe484cc6ad1b594b7260e88e
record_format Article
spelling doaj-21e94783fe484cc6ad1b594b7260e88e2021-04-02T03:29:43ZengBMCBMC Medical Genomics1755-87942010-10-01314710.1186/1755-8794-3-47Admixture mapping of end stage kidney disease genetic susceptibility using estimated mutual information ancestry informative markersGeiger DanTempleton AlanYudkovsky GuennadyWasser Walter GBercovici SivanShlush Liran ISkorecki Karl<p>Abstract</p> <p>Background</p> <p>The question of a genetic contribution to the higher prevalence and incidence of end stage kidney disease (ESKD) among African Americans (AA) remained unresolved, until recent findings using admixture mapping pointed to the association of a genomic locus on chromosome 22 with this disease phenotype. In the current study we utilize this example to demonstrate the utility of applying a multi-step admixture mapping approach.</p> <p>Methods</p> <p>A multi-step case only admixture mapping study, consisted of the following steps was designed: 1) Assembly of the sample dataset (ESKD AA); 2) Design of the estimated mutual information ancestry informative markers (n = 2016) screening panel 3); Genotyping the sample set whose size was determined by a power analysis (n = 576) appropriate for the initial screening panel; 4) Inference of local ancestry for each individual and identification of regions with increased AA ancestry using two different ancestry inference statistical approaches; 5) Enrichment of the initial screening panel; 6) Power analysis of the enriched panel 7) Genotyping of additional samples. 8) Re-analysis of the genotyping results to identify a genetic risk locus.</p> <p>Results</p> <p>The initial screening phase yielded a significant peak using the ADMIXMAP ancestry inference program applying case only statistics. Subgroup analysis of 299 ESKD patients with no history of diabetes yielded peaks using both the ANCESTRYMAP and ADMIXMAP ancestry inference programs. The significant peak was found on chromosome 22. Genotyping of additional ancestry informative markers on chromosome 22 that took into account linkage disequilibrium in the ancestral populations, and the addition of samples increased the statistical significance of the finding.</p> <p>Conclusions</p> <p>A multi-step admixture mapping analysis of AA ESKD patients replicated the finding of a candidate risk locus on chromosome 22, contributing to the heightened susceptibility of African Americans to develop non-diabetic ESKD, and underscores the importance of using mutual information and multiple ancestry inference approaches to achieve a robust analysis, using relatively small datasets of "affected" only individuals. The current study suggests solutions to some limitations of existing admixture mapping methodologies, such as considerations regarding the distribution of ancestry information along the genome and its effects on power calculations and sample size.</p> http://www.biomedcentral.com/1755-8794/3/47
collection DOAJ
language English
format Article
sources DOAJ
author Geiger Dan
Templeton Alan
Yudkovsky Guennady
Wasser Walter G
Bercovici Sivan
Shlush Liran I
Skorecki Karl
spellingShingle Geiger Dan
Templeton Alan
Yudkovsky Guennady
Wasser Walter G
Bercovici Sivan
Shlush Liran I
Skorecki Karl
Admixture mapping of end stage kidney disease genetic susceptibility using estimated mutual information ancestry informative markers
BMC Medical Genomics
author_facet Geiger Dan
Templeton Alan
Yudkovsky Guennady
Wasser Walter G
Bercovici Sivan
Shlush Liran I
Skorecki Karl
author_sort Geiger Dan
title Admixture mapping of end stage kidney disease genetic susceptibility using estimated mutual information ancestry informative markers
title_short Admixture mapping of end stage kidney disease genetic susceptibility using estimated mutual information ancestry informative markers
title_full Admixture mapping of end stage kidney disease genetic susceptibility using estimated mutual information ancestry informative markers
title_fullStr Admixture mapping of end stage kidney disease genetic susceptibility using estimated mutual information ancestry informative markers
title_full_unstemmed Admixture mapping of end stage kidney disease genetic susceptibility using estimated mutual information ancestry informative markers
title_sort admixture mapping of end stage kidney disease genetic susceptibility using estimated mutual information ancestry informative markers
publisher BMC
series BMC Medical Genomics
issn 1755-8794
publishDate 2010-10-01
description <p>Abstract</p> <p>Background</p> <p>The question of a genetic contribution to the higher prevalence and incidence of end stage kidney disease (ESKD) among African Americans (AA) remained unresolved, until recent findings using admixture mapping pointed to the association of a genomic locus on chromosome 22 with this disease phenotype. In the current study we utilize this example to demonstrate the utility of applying a multi-step admixture mapping approach.</p> <p>Methods</p> <p>A multi-step case only admixture mapping study, consisted of the following steps was designed: 1) Assembly of the sample dataset (ESKD AA); 2) Design of the estimated mutual information ancestry informative markers (n = 2016) screening panel 3); Genotyping the sample set whose size was determined by a power analysis (n = 576) appropriate for the initial screening panel; 4) Inference of local ancestry for each individual and identification of regions with increased AA ancestry using two different ancestry inference statistical approaches; 5) Enrichment of the initial screening panel; 6) Power analysis of the enriched panel 7) Genotyping of additional samples. 8) Re-analysis of the genotyping results to identify a genetic risk locus.</p> <p>Results</p> <p>The initial screening phase yielded a significant peak using the ADMIXMAP ancestry inference program applying case only statistics. Subgroup analysis of 299 ESKD patients with no history of diabetes yielded peaks using both the ANCESTRYMAP and ADMIXMAP ancestry inference programs. The significant peak was found on chromosome 22. Genotyping of additional ancestry informative markers on chromosome 22 that took into account linkage disequilibrium in the ancestral populations, and the addition of samples increased the statistical significance of the finding.</p> <p>Conclusions</p> <p>A multi-step admixture mapping analysis of AA ESKD patients replicated the finding of a candidate risk locus on chromosome 22, contributing to the heightened susceptibility of African Americans to develop non-diabetic ESKD, and underscores the importance of using mutual information and multiple ancestry inference approaches to achieve a robust analysis, using relatively small datasets of "affected" only individuals. The current study suggests solutions to some limitations of existing admixture mapping methodologies, such as considerations regarding the distribution of ancestry information along the genome and its effects on power calculations and sample size.</p>
url http://www.biomedcentral.com/1755-8794/3/47
work_keys_str_mv AT geigerdan admixturemappingofendstagekidneydiseasegeneticsusceptibilityusingestimatedmutualinformationancestryinformativemarkers
AT templetonalan admixturemappingofendstagekidneydiseasegeneticsusceptibilityusingestimatedmutualinformationancestryinformativemarkers
AT yudkovskyguennady admixturemappingofendstagekidneydiseasegeneticsusceptibilityusingestimatedmutualinformationancestryinformativemarkers
AT wasserwalterg admixturemappingofendstagekidneydiseasegeneticsusceptibilityusingestimatedmutualinformationancestryinformativemarkers
AT bercovicisivan admixturemappingofendstagekidneydiseasegeneticsusceptibilityusingestimatedmutualinformationancestryinformativemarkers
AT shlushlirani admixturemappingofendstagekidneydiseasegeneticsusceptibilityusingestimatedmutualinformationancestryinformativemarkers
AT skoreckikarl admixturemappingofendstagekidneydiseasegeneticsusceptibilityusingestimatedmutualinformationancestryinformativemarkers
_version_ 1724173771719311360